High Purity New England Launches Third Facility

Article

High Purity New England has launched its third facility, focused on single-use assemblies.

High Purity New England (HPNE), a supplier of single-use solutions for the biopharmaceutical industry, has launched its third new state-of-the-art facility. The facility is designed to accelerate HPNE’s ability to provide its customers with single-use assemblies and significantly increase the company’s manufacturing capacity.

The facility represents a $10 million investment, sized at approximately 80,000 square feet. It will serve as the company’s Specialty Manufacturing and Distribution Center. The facility features an extensive laboratory with four suites, an auditorium, a mock cleanroom for onboarding employees to practice gowning and S.O.P training, and two floors of warehouse space for materials and finished goods. It will also house additional office space and community space used for industry and local organizations, such as the Boys & Girls’ Club of RI and RI Bio.

HPNE supplies a range of products, including custom single-use assemblies, pumps, mixers, and other single-use solutions. The company’s total square footage is now greater than 130,000 square feet with the addition of the new facility, increasing their abilities to provide products to its customers.

Source: HPNE

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Behind the Headlines, Episode 21: Waters-BD Merger, Merck’s $10B Bet, and Biotech’s Investment Frontiers
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Jason Waite, International Trade Expert, Alston & Bird
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.